Highly efficient cationic ethylphosphatidylcholine siRNA carrier for GFP suppression in modified breast cancer cells

Anticancer Research

Volumn 32, Issue 7, 2012, Pages 2563-2566

  Tenchov, Boris ^a   Sugimoto, Yasuro ^a   Koynova, Rumiana ^a   Brueggemeier, Robert W ^a   Lee, Robert J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Cationic lipid; Ethylphosphatidylcholine; MCF 7 breast cancer cells; Non viral vector; SiRNA

Indexed keywords

CATIONIC ETHYLPHOSPHATIDYLCHOLINE; GREEN FLUORESCENT PROTEIN; LIPID; LIPOFECTAMINE; NANOPARTICLE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; DRUG FORMULATION; ENDOTHELIUM CELL; GENE DELIVERY SYSTEM; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LIPID ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; UMBILICAL ARTERY;

BREAST NEOPLASMS; CATIONS; CELL LINE, TUMOR; FEMALE; GENE THERAPY; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; NANOPARTICLES; OLEIC ACIDS; PHOSPHATIDYLCHOLINES; RNA, SMALL INTERFERING; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 84865699818     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Felgner PL and Ringold GM: Cationic liposome-mediated transfection. Nature 337: 387-388, 1989.
2. Leventis R and Silvius JR: Interactions of mammalian-cells with lipid dispersions containing novel metabolizable cationic amphiphiles. Biochim Biophys Acta 1023: 124-132, 1990.
3. Gao X and Huang L: A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun 179: 280-285, 1991.
4. Felgner PL: Prospects for synthetic self-assembling systems in gene delivery. J Gene Med 1: 290-292, 1999.
5. Ilies MA, Seitz WA and Balaban AT: Cationic lipids in gene delivery: Principles, vector design and therapeutical applications. Curr Pharm Des 8: 2441-2473, 2002.
6. Gascon AR and Pedraz JL: Cationic lipids as gene transfer agents: a patent review. Exp Opin Ther Patents 18: 515-524, 2008.
7. Liu DX, Ren T and Gao X: Cationic transfection lipids. Curr Med Chem 10: 1307-1315, 2003.
8. Martin B, Sainlos M, Aissaoui A, Oudrhiri N, Hauchecorne M, Vigneron JP, Lehn JM and Lehn P: The design of cationic lipids for gene delivery. Curr Pharm Des 11: 375-394, 2005.
9. McNeil SE and Perrie Y: Gene delivery using cationic liposomes. Exp Opin Ther Patents 16: 1371-1382, 2006.
10. Semple SC, Akinc A, Chen JX, Sandhu AP, Mui BL, Cho CK, Sah DWY, Stebbing D, Crosley EJ, Yaworski E, Hafez IM, Dorkin JR, Qin J, Lam K, Rajeev KG, Wong KF, Jeffs LB, Nechev L, Eisenhardt ML, Jayaraman M, Kazem M, Maier MA, Srinivasulu M, Weinstein MJ, Chen QM, Alvarez R, Barros SA, De S, Klimuk SK, Borland T, Kosovrasti V, Cantley WL, Tam YK, Manoharan M, Ciufolini MA, Tracy MA, de Fougerolles A, MacLachlan I, Cullis PR, Madden TD and Hope MJ: Rational design of cationic lipids for siRNA delivery. Nat Biotechnol 28: 172-U18, 2010.
11. Love KT, Mahon KP, Levins CG, Whitehead KA, Querbes W, Dorkin JR, Qin J, Cantley W, Qin LL, Racie T, Frank-Kamenetsky M, Yip KN, Alvarez R, Sah DWY, de Fougerolles A, Fitzgerald K, Koteliansky V, Akinc A, Langer R and Anderson DG: Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci USA 107: 1864-1869, 2010.
12. MacDonald RC, Rakhmanova VA, Choi KL, Rosenzweig HS and Lahiri MK: O-Ethylphosphatidylcholine: A metabolizable cationic phospholipid which is a serum-compatible DNA transfection agent. J Pharm Sci 88: 896-904, 1999.
13. MacDonald RC, Ashley GW, Shida MM, Rakhmanova VA, Tarahovsky YS, Pantazatos DP, Kennedy MT, Pozharski EV, Baker KA, Jones RD, Rosenzweig HS, Choi KL, Qiu RZ and McIntosh TJ: Physical and biological properties of cationic triesters of phosphatidylcholine. Biophys J 77: 2612-2629, 1999.
14. Noone PG, Hohneker KW, Zhou ZQ, Johnson LG, Foy C, Gipson C, Jones K, Noah TL, Leigh MW, Schwartzbach C, Efthimiou J, Pearlman R, Boucher RC and Knowles MR: Safety and biological efficacy of a lipid FTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol Ther 1: 105-114, 2000.
15. Das A and Niven R: Use of perfluorocarbon (Fluorinert) to enhance reporter gene expression following intratracheal instillation into the lungs of Balb/c mice: Implications for nebulized delivery of plasmids. J Pharm Sci 90: 1336-1344, 2001.
16. McDonald RJ, Liggitt HD, Roche L, Nguyen HT, Pearlman R, Raabe OG, Bussey LB and Gorman CM: Aerosol delivery of lipid: DNA complexes to lungs of rhesus monkeys. Pharm Res 15: 671-679, 1998.
17. Gorman CM, Aikawa M, Fox B, Fox E, Lapuz C, Michaud B, Nguyen H, Roche E, Sawa T, and WienerKronish JP: Efficient in vivo delivery of DNA to pulmonary cells using the novel lipid EDMPC. Gene Ther 4: 983-992, 1997.
18. Faneca H, Simoes S and de Lima MCP: Association of albumin or protamine to lipoplexes: enhancement of transfection and resistance to serum. J Gene Med 6: 681-692, 2004.
19. Faneca H, Cabrita AS, Simoes S and de Lima MCP: Evaluation of the antitumoral effect mediated by IL-12 and HSV-tk genes when delivered by a novel lipid-based system. Biochim Biophys Acta-Biomembranes 1768: 1093-1102, 2007.
20. Faneca H, Faustino A and de Lima MCP: Synergistic antitumoral effect of vinblastine and HSV-Tk/GCV gene therapy mediated by albumin-associated cationic liposomes. J Controlled Release 126: 175-184, 2008.
21. Koynova R and Tenchov B: Cationic phospholipids - structure/transfection activity relationships. Soft Matter 5: 3187-3200, 2009.
22. Koynova R and Tenchov B: Cationic lipids: Molecular structure/ transfection activity relationships and interactions with biomembranes. In: Topics in Current Chemistry: Nucleic Acid Transfection. Bielke W and Erbacher C (eds.). Berlin, Springer-Verlag, pp. 51-93, 2010.
23. Tenchov BG, Wang L, Koynova R and MacDonald RC: Modulation of a membrane lipid lamellar-nonlamellar phase transition by cationic lipids: a measure for transfection efficiency. Biochim Biophys Acta 1778: 2405-2412, 2008.
24. Koynova R, Tenchov B, Wang L and MacDonald RC: Hydrophobic moiety of cationic lipids strongly modulates their transfection activity. Mol Pharmaceut 6: 951-958, 2009.
25. Wang L and MacDonald RC: New strategy for transfection: mixtures of medium-chain and long-chain cationic lipids synergistically enhance transfection. Gene Ther 11: 1358-1362, 2004.
26. Koynova R, Tarahovsky Y, Wang L and MacDonald RC: Lipoplex formulation of superior efficacy exhibits high surface activity and fusogenicity, and readily releases DNA. Biochim Biophys Acta 1768: 375-386, 2007.